Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: A systematic review and meta-analysis of randomized controlled trials

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Liu, Bolin ^a   Liu, Shujuan ^b   Yin, Anan ^b   Siddiqi, Javed ^a  

^a ARROWHEAD REGIONAL MEDICAL CENTER   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CHEMOPROPHYLAXIS; CONTINUOUS INFUSION; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFORMATION RETRIEVAL; INTENSIVE CARE; META ANALYSIS; MORTALITY; NEUROCRITICAL CARE PATIENT; OUTCOME ASSESSMENT; PATIENT; PNEUMONIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; STRESS ULCER; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL BLEEDING; ADULT; BRAIN INJURY; COMPLICATION; MENTAL STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STOMACH ULCER;

ADULT; BRAIN INJURIES; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

EID: 84946903649     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1107-2     Document Type: Article

References (37)

1. Krag M, Perner A, Wetterslev J, Moller MH. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiol Scand. 2013;57(7):835-47.
2. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330(6):377-81.
3. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56(4):347-79.
4. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637.
5. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Møller M. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med. 2014;40(1):11-22.
6. Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med. 2010;38(4):1197-205.
7. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med. 2010;38(11):2222-8.
8. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013;41(3):693-705.
9. Barkun AN, Bardou M, Pham CQ, Martel M. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol. 2012;107(4):507-21.
10. Kamada T, Fusamoto H, Kawano S, Noguchi M, Hiramatsu K. Gastrointestinal bleeding following head injury: a clinical study of 433 cases. J Trauma. 1977;17(1):44-7.
11. Reusser P, Gyr K, Scheidegger D, Buchmann B, Buser M, Zimmerli W. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990;18(3):270-4.
12. Burgess P, Larson GM, Davidson P, Brown J, Metz CA. Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury. Dig Dis Sci. 1995;40(3):645-50.
13. Halloran LG, Zfass AM, Gayle WE, Wheeler CB, Miller JD. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg. 1980;139(1):44-8.
14. Metz CA, Livingston DH, Smith JS, Larson GM, Wilson TH, Larson GM, et al. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. Crit Care Med. 1993;21(12):1844-9.
15. Misra UK, Kalita J, Pandey S, Mandal SK, Srivastava M. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci. 2005;239(1):5-10.
16. Liu BL, Li B, Zhang X, Fei Z, Hu SJ, Lin W, et al. A randomized controlled study comparing omeprazole and cimetidine for the prophylaxis of stress-related upper gastrointestinal bleeding in patients with intracerebral hemorrhage. J Neurosurg. 2013;118(1):115-20.
17. O'Donnell MJ, Kapral MK, Fang J, Saposnik G, Eikelboom JW, Oczkowski W, et al. Gastrointestinal bleeding after acute ischemic stroke. Neurology. 2008;71(9):650-5.
18. Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006;101(7):1655-65.
19. Hamidon BB, Raymond AA. The risk factors of gastrointestinal bleeding in acute ischaemic stroke. Med J Malaysia. 2006;61(3):288-91.
20. Fabian TC, Boucher BA, Croce MA, Kuhl DA, Janning SW, Coffey BC, et al. Pneumonia and stress ulceration in severely injured patients: A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg. 1993;128(2):185-92.
21. Leramo OB, Tator CH, Hudson AR. Massive gastroduodenal hemorrhage and perforation in acute spinal cord injury. Surg Neurol. 1982;17(3):186-90.
22. Chan KH, Lai ECS, Tuen H, Ngan JHK, Mok F, Fan YW, et al. Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. J Neurosurg. 1995;82(3):413-7.
23. Schirmer CM, Kornbluth J, Heilman CB, Bhardwaj A. Gastrointestinal prophylaxis in neurocritical care. Neurocrit Care. 2012;16(1):184-93.
24. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. Oxford, UK: The Cochrane Collaboration; 2011.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
26. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203.
27. Huang J, Cao Y, Liao C, Wu L, Gao F. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit Care. 2010;14:R194.
28. Zhang YH, Wu P, Wu S. [Combined use of GM1 with proton-pump inhibitors or H2-receptor antagonists for treatment of spontaneous intracerebral hemorrhage with upper digestive tract hemorrhage]. World Chin J Digestology. 2014;22(26):3958-62. Chinese.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.
30. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336(7644):601-5.
31. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol. 2009;9:1.
32. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006;1:CD002094.
33. Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, et al. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol. 2013;66(9):973-81.
34. Hernandez DE. Neuroendocrine mechanisms of stress ulceration: focus on thyrotropin-releasing hormone (TRH). Life Sci. 1986;39(4):279-96.
35. Yang YX, Lewis JD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis. 2003;14(1):11-9.
36. Cushing H. Peptic ulcer and the interbrain. Surg Gynecol Obstet. 1932;55:1-34.
37. Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care. 2007;18(2):119-28.